627 related articles for article (PubMed ID: 8517647)
21. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
[TBL] [Abstract][Full Text] [Related]
22. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
23. In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia.
Schröder JK; Kasimir-Bauer S; Seeber S; Scheulen ME
J Cancer Res Clin Oncol; 2000 Feb; 126(2):111-6. PubMed ID: 10664252
[TBL] [Abstract][Full Text] [Related]
24. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
25. Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Kuffel MJ; Reid JM; Ames MM
Cancer Chemother Pharmacol; 1992; 30(1):51-7. PubMed ID: 1586980
[TBL] [Abstract][Full Text] [Related]
26. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
27. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
Potemski P; Polakowski P
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
[TBL] [Abstract][Full Text] [Related]
28. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
29. [Clinical pharmacology of idarubicin].
Robak T
Acta Haematol Pol; 1993; 24(4):315-26. PubMed ID: 8303977
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Yamagami K; Fujii A; Arita M; Okumoto T; Sakata S; Matsuda A; Ueda T; Sasaki T
Cancer Res; 1991 May; 51(9):2319-23. PubMed ID: 2015596
[TBL] [Abstract][Full Text] [Related]
31. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
Inaba M; Maruyama E
Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
[TBL] [Abstract][Full Text] [Related]
32. [In vitro effect of combined use of BH-AC and nitrosourea derivatives against adriamycin-resistant human leukemia cell line].
Oguro M; Sakai C; Takagi T; Matsuura Y
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2403-8. PubMed ID: 1952959
[TBL] [Abstract][Full Text] [Related]
33. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
34. Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
Bassan R; Chiodini B; Zucchetti M; Lerede T; Cornelli PE; Cortelazzo S; Barbui T
Haematologica; 1998 Jan; 83(1):27-33. PubMed ID: 9542320
[TBL] [Abstract][Full Text] [Related]
35. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
36. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
37. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
[TBL] [Abstract][Full Text] [Related]
38. Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia.
Zhang G; Fang L; Zhu L; Zhong Y; Wang PG; Sun D
J Med Chem; 2006 Mar; 49(5):1792-9. PubMed ID: 16509594
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetics and action mechanism of anthracyclines].
Fukushima T; Ueda T; Nakamura T
Gan To Kagaku Ryoho; 1992 Apr; 19(4):445-50. PubMed ID: 1558393
[TBL] [Abstract][Full Text] [Related]
40. [Study for modifying activity of solvents on antitumor activity of paclitaxel].
Fujimoto S
Gan To Kagaku Ryoho; 1994 Apr; 21(5):665-70. PubMed ID: 7908793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
